SCM
CLPT icon

Sterling Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Sterling Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Sell
99
-78
-44% -$974 ﹤0.01% 3022
2026
Q1 		$1.61K Hold
177
– – ﹤0.01% 3029
2025
Q4 		$2.42K Buy
177
+113
+177% +$2.1K ﹤0.01% 3043
2025
Q3 		$1.4K Buy
64
+1
+2% +$12 ﹤0.01% 3032
2025
Q2 		$752 Buy
+63
New +$793 ﹤0.01% 3105

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Sterling Capital Management's CLPT Position: Q2 2026 in Review

Sterling Capital Management reduced its ClearPoint Neuro (CLPT) stake by 44% in Q2 2026, selling an estimated $974 and leaving 99 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3022.

Sterling Capital Management first reported a position in CLPT in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.42K in Q4 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Sterling Capital Management held 99 shares of ClearPoint Neuro worth $1.77K as of Q2 2026.
  • Sterling Capital Management sold 78 ClearPoint Neuro shares in Q2 2026, an estimated $974.
  • ClearPoint Neuro made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3022 holding.
  • Sterling Capital Management first reported a position in ClearPoint Neuro in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's ClearPoint Neuro position peaked at $2.42K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.